Williams B T, Stevens L M, Mueller T. "A Process for Preparing High-Purity (2-Cyclohexylamino-1-methylethyl) benzoate
1-(Cyclohexylamino)-2-propanol benzoate (ester)
1-(cyclohexylamino)propan-2-yl benzoate
2-Propanol, 1-(cyclohexylamino)-, benzoate (ester)
532-77-4
Cyclaine (TN)
D08MRN
Hexilcaina
Hexilcaina [INN-Spanish]
Hexylcaine
Hexylcaine [INN]
Hexylcainum
Hexylcainum [INN-Latin]
Osmocaine
Osmocaine (TN)" [P]. US Patent, US 9730920 B2, 2021-07-05.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2013, 1102, (11), 9377-9407.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2014, 1158, (11), 6506-6513.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of (2-Cyclohexylamino-1-methylethyl) benzoate
1-(Cyclohexylamino)-2-propanol benzoate (ester)
1-(cyclohexylamino)propan-2-yl benzoate
2-Propanol, 1-(cyclohexylamino)-, benzoate (ester)
532-77-4
Cyclaine (TN)
D08MRN
Hexilcaina
Hexilcaina [INN-Spanish]
Hexylcaine
Hexylcaine [INN]
Hexylcainum
Hexylcainum [INN-Latin]
Osmocaine
Osmocaine (TN) Using HRMS and NMR". J. Sep. Sci., 2019, 2041, 5855-5861.